Xeris Pharmaceuticals | XERS - Stock


Xeris Pharmaceuticals reported $80.93M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Celltrion KRW 126B 3.06B Mar/2026
Cspc Pharmaceutical CNY 3.09B 219.95M Dec/2025
Divis Laboratories Ltd INR 39.54B 7.18B Mar/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Kangmei Pharma CNY 2.38B 73.9M Mar/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma EUR 327.67M 2.28M Jun/2025
Medical Developments International AUD 9.45M 679K Jun/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Organigram Holdings CAD 135.16M 2.45M Mar/2026
Pacira USD 134.57M 15.8M Jun/2026
Perrigo USD 1.06B 56.9M Jun/2026
Pharma Mar EUR 49.53M 3.59M Jun/2026
Qiagen NV USD 309.61M 7.72M Mar/2026
Sartorius EUR 831.9M 4.8M Jun/2026
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Supernus Pharmaceuticals USD 107.03M 3.74M Jun/2026
Tilray USD 282.79M 11.9M Jun/2025
Zealand Pharma A/S 10.7M 9.9M Dec/2024
Zz Pientze Pharmaceu CNY 6.28B 553.86M Mar/2026